It’s a constant ASPIRE drip.
It’s an unknown -NO analyst coverage stock
It’s an iHub stock
I’ve played the pennies, the otcbb the pinks etc..... financial pressure always rules the day and that is where you find the most undervalued bargain stocks .... during times of raising money.
Leo has decided to go the long term responsible drip way. No huge CDs or other extreme toxic route, he has slowly milked over 40 million in shares into the market over the past 6 years. And believe me....to pay for 8 human trials and pick up 10 additional compounds is unheard of for only 40 plus million shares.
Nonetheless, it’s a constant pressure.
The minute we get validation and a deal this will re-evaluate in a flash.
Leo will only license IMO. ATLEAST first. The value of the company is no where near true value.
Everything will change in a blink soon enough.
Imo